Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Dominik Paul Modest, Anke Reinacher‐Schick, Thomas Kirchner et al.|Annals of Oncology|2016

Cited by 344